top of page

Doctolib: How a Booking App Became Europe's Health Operating System

6 days ago
3 min read

Updated: 4 days ago

Doctolib: How a Booking App Became Europe's Health Operating System

Doctolib, founded in Paris in 2013, has grown from a single appointment-booking tool into what it calls an operating system for doctors — around 80 million patient accounts and some 900,000 practitioners across France, Germany and Italy. Its growth story is really a trust story, with a cautionary twist.

From booking to backbone

Doctolib started by solving one unglamorous problem: booking a doctor's appointment online. Founder Stanislas Niox-Chateau then expanded it into a full suite — patient management, teleconsultation, records, admin — until the product became infrastructure that practices find hard to leave. In France it says it covers almost the entire population, and the government chose it to run vaccination bookings during Covid.

Why trust was the whole marketing strategy

You cannot growth-hack your way into healthcare. Doctolib's expansion rested on a reputation built slowly: with doctors, who had to believe the tool was reliable and secure, and with patients, who had to trust it with sensitive data. That reputation is the moat. Revenue is reported at nearly €300m, and roughly half of its practitioners pay — a network effect that compounds, because each doctor on the platform makes it more useful to patients, and vice versa.

The catch worth being honest about

Growth has not been frictionless. Germany, entered in 2016, took years to click because doctors there work differently; Italy, entered via an acquisition in 2021, stumbled and lost paying users. And while the company was valued at €5.8bn in its 2022 round, a 2026 secondary share sale reset that figure sharply lower — a reminder that paper valuations and real businesses move on different clocks. Doctolib's response has been to cut projects without clear returns and focus on profitability.

What businesses can take from it

The transferable lesson is that in any category where trust is the barrier to entry — health, finance, anything handling sensitive data — reputation is the growth engine, and it is built, not bought. Doctolib's playbook is patient: solve one real problem brilliantly, earn the right to solve the next one, and let network effects do the compounding. The warning is equally useful: expansion into new markets rarely copies and pastes, because trust is local and has to be re-earned each time.

Doctolib is proof that in the right category, trust is the best growth strategy there is — and the slowest to build. It did not win France with clever ads; it won by being the thing doctors and patients could rely on, for years, until leaving felt unthinkable. Every market it entered after that, it had to earn all over again. — Daniel Nikolla, Founder of Merx Marketing

In any trust-based category, reputation is the growth engine — and it is built slowly, one solved problem at a time. It also does not copy-paste across borders.

In your business, is trust a marketing message you broadcast — or something you have genuinely earned the hard way?

If you would like to know more about this topic, please contact us on danieln@merxmarketing.co.uk

Sources: Sifted, TechCrunch, Dealroom.

Related reading

Written by Daniel Nikolla, Founder of Merx Marketing Ltd and Marketing Minute

bottom of page
Website by Merx Marketing
Share

⚡ Stay ahead in a minute

The biggest UK marketing stories — and what they mean for your business — every week.

Get the Weekly Digest →
Enter